BioHarvest Sciences (BHST) Cash From Financing

Annual CFF

$13.56 M
+$5.42 M+66.58%

December 1, 2023

Summary

Performance

1-Year Change

+66.58%

3-Year Change

+175.19%

5-Year Change

+508.71%

15-Year Change

+18393.86%

BHST Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$13.56 M
BHST annual cash flow from financing activities is currently at an all-time high

3-Year Low

$8.14 M
BHST annual cash flow from financing activities is currently +66.58% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
BHST previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

N/A
BHST next annual earnings announcement has not yet been scheduled

OtherBHSTcash flowmetrics:

Annual CFI

-$1.47 M
BHST annual cash flow from investing activities is -$1.47 million

Annual CFO

-$8.52 M
BHST annual cash flow from operations is -$8.52 million

Annual FCF

-$10.00 M
BHST annual free cash flow is -$10.00 million

Annual CAPEX

$1.47 M
BHST annual capital expenditures is $1.47 million

Quarterly CFF

-$164.00 K
-$4.77 M-103.56%

September 1, 2024

Summary

Performance

3-Month Change

-103.56%

1-Year Change

-113.86%

3-Year Change

-103.13%

5-Year Change

-103.13%

BHST Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$7.01 M
BHST quarterly cash flow from financing activities is currently -102.34% below its historical high of $7.01 million

3-Year Low

-$164.00 K
BHST quarterly cash flow from financing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
BHST previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
BHST next earnings announcement has not yet been scheduled

OtherBHSTcash flowmetrics:

Quarterly CFI

-$472.00 K
BHST quarterly cash flow from investing activities is -$472.00 thousand

Quarterly CFO

-$1.76 M
BHST quarterly cash flow from operations is -$1.76 million

Quarterly FCF

-$2.27 M
BHST quarterly free cash flow is -$2.27 million

Quarterly CAPEX

$512.00 K
BHST quarterly capital expenditures is $512.00 thousand

TTM CFF

$11.34 M
-$1.35 M-10.62%

September 1, 2024

Summary

Performance

3-Month Change

-10.62%

1-Year Change

+29.13%

3-Year Change

+1.31%

5-Year Change

+1.31%

BHST TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$13.56 M
BHST TTM cash flow from financing activities is currently -16.38% below its historical high of $13.56 million

3-Year Low

$5.18 M
BHST TTM cash flow from financing activities is currently +118.70% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
BHST previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
BHST next earnings announcement has not yet been scheduled

OtherBHSTcash flowmetrics:

TTM CFI

-$2.92 M
BHST TTM cash flow from investing activities is -$2.92 million

TTM CFO

-$7.29 M
BHST TTM cash flow from operations is -$7.29 million

TTM FCF

-$10.02 M
BHST TTM free cash flow is -$10.02 million

TTM CAPEX

$2.73 M
BHST TTM capital expenditures is $2.73 million

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

BHST Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+66.6%-113.9%+29.1%
3 y3 years+175.2%-103.1%+1.3%
5 y5 years+508.7%-103.1%+1.3%

BHST Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high-40.0%-102.3%at low-16.4%-54.3%
5 y5-yearat high-84.3%-102.3%at low-16.4%-86.0%
alltimeall timeat high-99.5%-102.3%+27.0%-16.4%-99.6%

BioHarvest Sciences Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$164.00 K(-103.6%)
$11.34 M(-10.6%)
Jun 2024
-
$4.61 M(-4070.7%)
$12.68 M(-1.1%)
Mar 2024
-
-$116.00 K(-101.7%)
$12.82 M(-5.4%)
Dec 2023
$13.56 M(+66.6%)
$7.01 M(+492.5%)
$13.56 M(+54.4%)
Sep 2023
-
$1.18 M(-75.1%)
$8.78 M(-23.2%)
Jun 2023
-
$4.75 M(+669.4%)
$11.43 M(+31.2%)
Mar 2023
-
$617.00 K(-72.3%)
$8.71 M(+7.1%)
Dec 2022
$8.14 M(-24.5%)
$2.23 M(-41.8%)
$8.14 M(+39.0%)
Sep 2022
-
$3.83 M(+89.0%)
$5.85 M(-19.4%)
Jun 2022
-
$2.03 M(+4618.6%)
$7.26 M(+40.1%)
Mar 2022
-
$43.00 K(-181.1%)
$5.18 M(-51.9%)
Dec 2021
$10.77 M(+118.7%)
-$53.00 K(-101.0%)
$10.77 M(-3.7%)
Sep 2021
-
$5.24 M(<-9900.0%)
$11.19 M(+29.2%)
Jun 2021
-
-$50.00 K(-100.9%)
$8.66 M(-3.5%)
Mar 2021
-
$5.63 M(+1451.5%)
$8.97 M(+82.2%)
Dec 2020
$4.93 M(+132.1%)
$363.00 K(-86.6%)
$4.93 M(+8.0%)
Sep 2020
-
$2.71 M(+919.9%)
$4.56 M(+146.6%)
Jun 2020
-
$266.00 K(-83.2%)
$1.85 M(+16.8%)
Mar 2020
-
$1.58 M
$1.58 M
DateAnnualQuarterlyTTM
Dec 2019
$2.12 M(-4.7%)
-
-
Apr 2019
$2.23 M(+411.8%)
$2.23 M(+969.6%)
$2.23 M(+3049.9%)
Oct 2018
-
$208.20 K(-200.0%)
$70.70 K(-67.7%)
Jul 2018
-
-$208.20 K(+544.6%)
$218.90 K(-49.7%)
Apr 2018
$435.10 K(+493.6%)
-$32.30 K(-131.4%)
$435.10 K(-6.3%)
Jan 2018
-
$103.00 K(-71.1%)
$464.40 K(+20.5%)
Oct 2017
-
$356.40 K(+4355.0%)
$385.50 K(+484.1%)
Jul 2017
-
$8000.00(-366.7%)
$66.00 K(-10.0%)
Apr 2017
$73.30 K(-56.2%)
-$3000.00(-112.4%)
$73.30 K(-36.9%)
Jan 2017
-
$24.10 K(-34.7%)
$116.20 K(+39.5%)
Oct 2016
-
$36.90 K(+141.2%)
$83.30 K(-54.4%)
Jul 2016
-
$15.30 K(-61.7%)
$182.50 K(+9.2%)
Apr 2016
$167.20 K(+76.0%)
$39.90 K(-553.4%)
$167.20 K(+12.7%)
Jan 2016
-
-$8800.00(-106.5%)
$148.30 K(-22.4%)
Oct 2015
-
$136.10 K(>+9900.0%)
$191.00 K(+100.8%)
Jul 2015
-
$0.00(-100.0%)
$95.10 K(0.0%)
Apr 2015
$95.00 K(-20.9%)
$21.00 K(-38.1%)
$95.10 K(+28.3%)
Jan 2015
-
$33.90 K(-15.7%)
$74.10 K(+84.3%)
Oct 2014
-
$40.20 K
$40.20 K
Apr 2014
$120.10 K
-
-

FAQ

  • What is BioHarvest Sciences annual cash flow from financing activities?
  • What is the all time high annual CFF for BioHarvest Sciences?
  • What is BioHarvest Sciences annual CFF year-on-year change?
  • What is BioHarvest Sciences quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for BioHarvest Sciences?
  • What is BioHarvest Sciences quarterly CFF year-on-year change?
  • What is BioHarvest Sciences TTM cash flow from financing activities?
  • What is the all time high TTM CFF for BioHarvest Sciences?
  • What is BioHarvest Sciences TTM CFF year-on-year change?

What is BioHarvest Sciences annual cash flow from financing activities?

The current annual CFF of BHST is $13.56 M

What is the all time high annual CFF for BioHarvest Sciences?

BioHarvest Sciences all-time high annual cash flow from financing activities is $13.56 M

What is BioHarvest Sciences annual CFF year-on-year change?

Over the past year, BHST annual cash flow from financing activities has changed by +$5.42 M (+66.58%)

What is BioHarvest Sciences quarterly cash flow from financing activities?

The current quarterly CFF of BHST is -$164.00 K

What is the all time high quarterly CFF for BioHarvest Sciences?

BioHarvest Sciences all-time high quarterly cash flow from financing activities is $7.01 M

What is BioHarvest Sciences quarterly CFF year-on-year change?

Over the past year, BHST quarterly cash flow from financing activities has changed by -$1.35 M (-113.86%)

What is BioHarvest Sciences TTM cash flow from financing activities?

The current TTM CFF of BHST is $11.34 M

What is the all time high TTM CFF for BioHarvest Sciences?

BioHarvest Sciences all-time high TTM cash flow from financing activities is $13.56 M

What is BioHarvest Sciences TTM CFF year-on-year change?

Over the past year, BHST TTM cash flow from financing activities has changed by +$2.56 M (+29.13%)